IP Library Granted Patent US 8,735,119
Granted Patent B2
US 8,735,119 · App. 13/954,682 · Granted May 27, 2014

Polypeptides having colanic acid-degrading activity

Inventor: Nancy Smyth Templeton (Houston, TX)
Assignee: Gradalis, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,735,119
App. No.
13/954,682
Granted
May 27, 2014
Kind
B2
Abstract

The present disclosure generally relates to polypeptides having colanic acid-degrading activity and methods of using the same. Polynucleotides encoding such polypeptides are also described. The polypeptides may be used, for example, in processes for degrading colanic acid, processes for the removal of endotoxins from biological samples, and processes for purifying plasmid DNA.

Claims (6)

1. A composition comprising a plasmid DNA preparation and a purified polypeptide having colanic acid-degrading activity comprising an amino acid sequence having at least 98% homology to SEQ ID NOS: 1 or 2.

2. The composition of claim 1 , therein the purified polypeptide having colanic acid-degrading activity comprising the amino acid sequence having at least 99% homology to SEQ ID NOS: 1 or 2.

3. The composition of claim 1 , therein the purified polypeptide having colanic acid-degrading activity comprising the amino acid sequence of SEQ ID NOS: 1 or 2.

4. A composition comprising a purified DNA and a polypeptide having colanic acid-degrading activity comprising an amino acid sequence having at least 98% homology to SEQ ID NOS: 1 or 2.

5. The composition of claim 4 , therein the purified polypeptide having colonic acid-degrading activity comprising the amino acid sequence having at least 99% homology to SEQ ID NOS: 1 or 2.

6. The composition of claim 4 , therein the purified polypeptide having colonic acid-degrading activity comprising the amino acid sequence of SEQ ID NOS: 1 or 2.

Assignments (3)
MERGER Recorded May 3, 2018
From: STRIKE BIO, INC.
To: GRADALIS, INC.
Reel/Frame 045709/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2015
From: GRADALIS, INC.
To: STRIKE BIO, INC.
Reel/Frame 035603/0731 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2013
From: TEMPLETON, NANCY SMYTH
To: GRADALIS, INC.
Reel/Frame 030909/0177 →
Continuity (5)
Continuation 13858697 · Apr 8, 2013
Continuation 12433691 · Apr 30, 2009
Provisional Application 61125916 · Apr 30, 2008
Provisional Application 61125923 · Apr 30, 2008
Related Publication 20130309752A1 · Nov 21, 2013